AC Immune Ltd (ACIU) Coverage Initiated by Analysts at Credit Suisse Group AG
Credit Suisse Group AG started coverage on shares of AC Immune Ltd (NASDAQ:ACIU) in a note issued to investors on Tuesday, The Fly reports. The brokerage set an “outperform” rating on the stock.
Separately, Jefferies Group assumed coverage on AC Immune in a report on Tuesday. They issued a “buy” rating on the stock.
Shares of AC Immune (NASDAQ:ACIU) opened at 14.43 on Tuesday. The company has a 50-day moving average price of $16.17 and a 200 day moving average price of $16.17. The company has a market capitalization of $712.78 million and a P/E ratio of 31.17. AC Immune has a 1-year low of $13.01 and a 1-year high of $19.97.
This story is the sole property of American Banking News and it was originally published by American Banking News. If you are reading this story on another website, that means this article was illegally copied and re-published to this website in violation of U.S. and International copyright law. The original version of this article is available at https://www.americanbankingnews.com/2016/10/18/ac-immune-ltd-aciu-coverage-initiated-by-analysts-at-credit-suisse-group-ag.html
Receive News & Ratings for AC Immune Ltd Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for AC Immune Ltd and related companies with MarketBeat.com's FREE daily email newsletter.